Table 3.
Evolution of medications, clinical and biological features after the 1st biotherapy course
| N = 46 | Before treatment | After treatment | p value |
|---|---|---|---|
| Colchicine | 38/46 (82.6) | 21/44 (47.7) | < 0.001 |
| NSAID | 9/44 (20.5) | 6/44 (13.6) | 0.505 |
| Oral corticosteroids | 30/45 (66.7) | 21/45 (46.7) | 0.016 |
| Local corticosteroids | 12/44 (27.3) | 6/44 (13.6) | 0.077 |
| Urate-lowering therapy | 22/46 (47.8) | 31/45 (68.9) | 0.008 |
| Arthritis | 4.0 (2.0–5.0) | 0.0 (0.0–2.0) | < 0.001 |
| CRP | 39.0 (4.0–97.4) | 5.0 (1.8–9.0) | < 0.001 |
Data are presented as n (%) or median (Q1–Q3)
NSAID non-steroidal anti-inflammatory drug, CRP C-reactive protein